SCHEMBL18566273

SCHEMBL18566273

Cn1c2cc3ccccc3cc2c2cccc(-c3ccc4c5ccccc5n(-c5ccccc5)c4c3)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ ATM Q13315 1/20 0.42
▸ ALKBH5 Q6P6C2 1/20 0.37
▸ FTO Q9C0B1 1/20 0.37
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ MAOB P27338 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.34
▸ RXFP1 Q9HBX9 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ LIMK1 P53667 1/20 0.33
▸ TLR4 O00206 1/20 0.33
▸ HSD17B10 Q99714 3/20 0.32
▸ HPGD P15428 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18563944 0.92 L3MBTL1 (0.47) KDM4EL3MBTL1ATMALKBH5FTO
SCHEMBL18563969 0.91 L3MBTL1 (0.44) KDM4EL3MBTL1ATMALKBH5FTO
SCHEMBL18566268 0.90 KDM4E (0.49) KDM4EL3MBTL1ATMALKBH5FTO
SCHEMBL18563977 0.89 KDM4E (0.50) KDM4EL3MBTL1ATMALKBH5FTO
SCHEMBL18563975 0.88 KDM4E (0.44) KDM4EL3MBTL1ATMALKBH5FTO
SCHEMBL18563981 0.88 KDM4E (0.44) KDM4EL3MBTL1ATMALKBH5FTO
SCHEMBL18563933 0.88 KDM4E (0.44) KDM4EL3MBTL1ATMALKBH5FTO
SCHEMBL18566269 0.86 KDM4E (0.50) KDM4EL3MBTL1ATMRXRARXRB
SCHEMBL18566275 0.86 KDM4E (0.42) KDM4EL3MBTL1ATMRXRARXRB
SCHEMBL18563995 0.85 KDM4E (0.46) KDM4EL3MBTL1ATMALKBH5FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 KDM4E 225/4885L3MBTL1 1263/4885ATM 3092/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 KDM4E 225/4885L3MBTL1 1263/4885ATM 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback